Aspen is in a closed period from 1st July 2026 until the publication of the annual results on the JSE SENS platform on the 2nd September 2026.

Aspen represented in high-level Africa–France dialogue on health and industrialization

Our Group Senior Executive: Strategic Trade, Stavros Nicolaou, recently represented the Group at AFRICA Day 2026, organised by the French-African Foundation in partnership with Sciences Po and AXIAN Group. His participation placed Aspen at the heart of important conversations about Africa’s pharmaceutical future, industrial development and investment-led growth.
Aspen represented in high-level Africa–France dialogue on health and industrialisation-1 Medium

Advancing Africa’s pharmaceutical capacity

During the event, Stavros addressed young, curious minds committed to building Africa’s future, describing the continent’s youth as its future industrialists. He shared Aspen’s contribution to the development of generic antiretroviral manufacturing in South Africa, demonstrating the role that strong local pharmaceutical capacity can play in expanding access to medicines. He also reflected on the next phase of pharmaceutical manufacturing on the continent, including the production of GLP-1 treatments.

 

Stavros emphasised that, as Africa works to shift the dial from commodities and minerals towards value-added manufacturing, pharmaceuticals must remain front and centre given the continent’s disease burden. These discussions highlighted the close connection between therapeutic innovation, manufacturing capability, access to medicines and stronger public health outcomes, while reinforcing the importance of sustainable African manufacturing ecosystems that can respond to evolving healthcare needs.

 

Contributing to the Africa Forward agenda

Following the Africa Forward Summit in Namibia, Stavros was invited to a working dinner at the Élysée Palace in Paris on 4 October 2026, hosted by the President of the French Republic, Emmanuel Macron.

 

The engagement was designed to consider the coalition’s structure and long-term sustainability, as well as cross-investment projects between France and African countries. It also offered a focused platform for dialogue on accelerating private investment, advancing industrialisation and creating value in Africa, particularly for young people.

 

Stavros’s participation in these high-level engagements reflects Aspen’s commitment to contributing meaningfully to conversations that shape Africa’s health, trade and industrial development. It further demonstrates how African pharmaceutical expertise, investment and the ambition of the continent’s next generation of industrialists can support greater health security, economic growth and long-term value creation across Africa.

 

Facebook
Twitter
LinkedIn

Closed Period

Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.

Corporate

Our career opportunities are across the corporate spectrum, including Human Capital, Digital Technology, Legal, and Risk & Sustainability. Our employees are given the opportunity to hone their skills and develop the experience of excellence in their chosen field in the pharmaceutical industry.

View our teams below: